Cargando…
Type I interferons as the potential mechanism linking mRNA COVID-19 vaccines to Bell's palsy
Autores principales: | Soeiro, Thomas, Salvo, Francesco, Pariente, Antoine, Grandvuillemin, Aurélie, Jonville-Béra, Annie-Pierre, Micallef, Joëlle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016545/ https://www.ncbi.nlm.nih.gov/pubmed/33858693 http://dx.doi.org/10.1016/j.therap.2021.03.005 |
Ejemplares similares
-
French Pharmacovigilance Public System and COVID-19 Pandemic
por: Grandvuillemin, Aurélie, et al.
Publicado: (2020) -
COVID-19 and NSAIDs: Primum non nocere
por: Micallef, Joëlle, et al.
Publicado: (2020) -
Non-steroidal anti-inflammatory drugs, pharmacology, and COVID-19 infection
por: Micallef, Joëlle, et al.
Publicado: (2020) -
French organization for the pharmacovigilance of COVID-19 vaccines: A major challenge
por: Lacroix, Clémence, et al.
Publicado: (2021) -
Pharmacovigilance des médicaments et des vaccins contre la COVID-19 durant la pandémie : comment le Réseau français des centres régionaux de pharmacovigilance a relevé le défi ?
por: Jonville-Bera, Annie Pierre, et al.
Publicado: (2023)